DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
BankPosition in TBPH — Theravance Biopharma, Inc.
CIK 1694217
FRANKFURT AM MAIN, 2M
Position in TBPH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,047,370
+$569,611 QoQ
Shares Held
64,533
+152.7% QoQ
Ownership
0.125%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TBPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main holds $379,217,691 across 26 Biotechnology names. TBPH ranks #22 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
364,513 | $162,769,634 | |
| 2 | BNTX |
BioNTech SE
|
387,214 | $34,415,577 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,270 | $29,568,932 | |
| 4 | INVA |
Innoviva, Inc.
|
892,336 | $20,791,428 | |
| 5 | INCY |
Incyte Corp
|
183,834 | $17,302,454 | |
| 6 | HRMY |
Harmony Biosciences Holdings, Inc.
|
567,115 | $15,884,891 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
213,363 | $14,536,421 | |
| 8 | EXEL |
Exelixis, Inc.
|
334,487 | $14,346,147 |
All Filings in TBPH
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,047,370 | 64,533 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $477,759 | 25,535 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $372,811 | 25,535 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||